Views & Analysis Medtech is key in fight against AMR Paul Chapman examines the challenge of antimicrobial resistance (AMR) and how it could be beaten.
Partner Content Partner Content AMR research, funding and incentives – updates at SMi event ... SMi reports: Antimicrobial resistance was predicted by Alexander Fleming in his Nobel lecture (1945).
News UK and Russian experts tackle superbugs The AMR Centre is to collaborate with Russia's Skolkovo Foundation
Partner Content Partner Content “SPARKing" New Antibiotic Drug Discovery “SPARKing" New Antibiotic Drug Discovery
Partner Content Partner Content Superbugs: Exclusive Interviews Released with ABAC Therapeut... Q&A's Out Ahead of Superbugs 2018
Partner Content Partner Content Agenda released for SMi’s 20th Annual Superbugs European Sho... Agenda released for 20th Annual Superbugs Event
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
